1-4 of 4
Oleg E. Akilov
Close
Sort by
Journal Articles

Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon

Tony T. Jiang, Oleg Kruglov, Oleg E. Akilov
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2384–2397.
https://doi.org/10.1182/bloodadvances.2023010043
Published: 2024
Includes: Supplemental data
Journal Articles

Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician’s choice in cutaneous T-cell lymphoma: final data

Clinical Trials & Observations
Steven M. Horwitz, Julia J. Scarisbrick, Reinhard Dummer, Sean Whittaker, Madeleine Duvic, Youn H. Kim, Pietro Quaglino, Pier Luigi Zinzani, Oliver Bechter, Herbert Eradat, Lauren Pinter-Brown, Oleg E. Akilov, Larisa Geskin, Jose A. Sanches, Pablo L. Ortiz-Romero, Michael Weichenthal, David C. Fisher, Jan Walewski, Judith Trotman, Kerry Taylor, Stephane Dalle, Rudolf Stadler, Julie Lisano, Veronica Bunn, Meredith Little, H. Miles Prince
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5098–5106.
https://doi.org/10.1182/bloodadvances.2021004710
Published: 2021
Includes: Supplemental data
Journal Articles

The synergistic proapoptotic effect of PARP-1 and HDAC inhibition in cutaneous T-cell lymphoma is mediated via Blimp-1

Oleg Kruglov, Xuesong Wu, Sam T. Hwang, Oleg E. Akilov
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4788–4797.
https://doi.org/10.1182/bloodadvances.2020002049
Published: 2020
Includes: Supplemental data
Journal Articles

Targeting CD47 in Sézary syndrome with SIRPαFc

Clinical Trials & Observations
Lisa D. S. Johnson, Swati Banerjee, Oleg Kruglov, Natasja Nielsen Viller, Steven M. Horwitz, Alexander Lesokhin, Jasmine Zain, Christiane Querfeld, Robert Chen, Craig Okada, Ahmed Sawas, Owen A. O’Connor, Eric L. Sievers, Yaping Shou, Robert A. Uger, Mark Wong, Oleg E. Akilov
Journal: Blood Advances
Blood Adv (2019) 3 (7): 1145–1153.
https://doi.org/10.1182/bloodadvances.2018030577
Published: 2019
Includes: Supplemental data